Avelumab
Avelumab market is segmented by region (country), players, by Type and by Application. Players, s ... Read More
Global and United States Atezolizumab Market Report & Forecast 2024-2031
1 Study Coverage
1.1 Atezolizumab Product Introduction
1.2 Global Atezolizumab Outlook 2017 VS 2022 VS 2028
1.2.1 Global Atezolizumab Sales in US$ Million for the Year 2017-2028
1.2.2 Global Atezolizumab Sales in Volume for the Year 2017-2028
1.3 United States Atezolizumab Outlook 2017 VS 2022 VS 2028
1.3.1 United States Atezolizumab Sales in US$ Million for the Year 2017-2028
1.3.2 United States Atezolizumab Sales in Volume for the Year 2017-2028
1.4 Atezolizumab Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Atezolizumab in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Atezolizumab Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Atezolizumab Market Dynamics
1.5.1 Atezolizumab Industry Trends
1.5.2 Atezolizumab Market Drivers
1.5.3 Atezolizumab Market Challenges
1.5.4 Atezolizumab Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Atezolizumab Market Segment by Type
2.1.1 Use: Single Drug
2.1.2 Use: Chemotherapy Combination
2.2 Global Atezolizumab Market Size by Type
2.2.1 Global Atezolizumab Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Atezolizumab Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Atezolizumab Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Atezolizumab Market Size by Type
2.3.1 United States Atezolizumab Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Atezolizumab Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Atezolizumab Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Atezolizumab Market Segment by Application
3.1.1 Bladder Cancer
3.1.2 Lung Cancer
3.1.3 Advanced Triple-negative Breast Cancer
3.1.4 Head and Neck Cancer
3.1.5 Urothelial Carcinoma
3.1.6 Renal Cell Carcinoma
3.1.7 Hepatocellular Carcinoma (HCC)
3.1.8 Other
3.2 Global Atezolizumab Market Size by Application
3.2.1 Global Atezolizumab Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Atezolizumab Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Atezolizumab Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Atezolizumab Market Size by Application
3.3.1 United States Atezolizumab Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Atezolizumab Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Atezolizumab Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Atezolizumab Competitor Landscape by Company
4.1 Global Atezolizumab Market Size by Company
4.1.1 Top Global Atezolizumab Manufacturers Ranked by Revenue (2021)
4.1.2 Global Atezolizumab Revenue by Manufacturer (2017-2022)
4.1.3 Global Atezolizumab Sales by Manufacturer (2017-2022)
4.1.4 Global Atezolizumab Price by Manufacturer (2017-2022)
4.2 Global Atezolizumab Concentration Ratio (CR)
4.2.1 Atezolizumab Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Atezolizumab in 2021
4.2.3 Global Atezolizumab Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Atezolizumab Manufacturing Base Distribution, Product Type
4.3.1 Global Atezolizumab Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Atezolizumab Product Type
4.3.3 Date of International Manufacturers Enter into Atezolizumab Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Atezolizumab Market Size by Company
4.5.1 Top Atezolizumab Players in United States, Ranked by Revenue (2021)
4.5.2 United States Atezolizumab Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Atezolizumab Sales by Players (2020, 2021 & 2022)
5 Global Atezolizumab Market Size by Region
5.1 Global Atezolizumab Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Atezolizumab Market Size in Volume by Region (2017-2028)
5.2.1 Global Atezolizumab Sales in Volume by Region: 2017-2022
5.2.2 Global Atezolizumab Sales in Volume Forecast by Region (2023-2028)
5.3 Global Atezolizumab Market Size in Value by Region (2017-2028)
5.3.1 Global Atezolizumab Sales in Value by Region: 2017-2022
5.3.2 Global Atezolizumab Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Atezolizumab Market Size YoY Growth 2017-2028
6.1.2 North America Atezolizumab Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Atezolizumab Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Atezolizumab Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Atezolizumab Market Size YoY Growth 2017-2028
6.3.2 Europe Atezolizumab Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Atezolizumab Market Size YoY Growth 2017-2028
6.4.2 Latin America Atezolizumab Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Atezolizumab Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Atezolizumab Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Genentech (Roche)
7.1.1 Genentech (Roche) Corporation Information
7.1.2 Genentech (Roche) Description and Business Overview
7.1.3 Genentech (Roche) Atezolizumab Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Genentech (Roche) Atezolizumab Products Offered
7.1.5 Genentech (Roche) Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Atezolizumab Industry Chain Analysis
8.2 Atezolizumab Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Atezolizumab Distributors
8.3 Atezolizumab Production Mode & Process
8.4 Atezolizumab Sales and Marketing
8.4.1 Atezolizumab Sales Channels
8.4.2 Atezolizumab Distributors
8.5 Atezolizumab Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Atezolizumab CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Atezolizumab Market Trends
Table 3. Atezolizumab Market Drivers
Table 4. Atezolizumab Market Challenges
Table 5. Atezolizumab Market Restraints
Table 6. Global Atezolizumab Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Atezolizumab Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Atezolizumab Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Atezolizumab Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Atezolizumab Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Atezolizumab Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Atezolizumab Revenue Share by Manufacturer, 2017-2022
Table 13. Global Atezolizumab Sales by Manufacturer, (K Pcs), 2017-2022
Table 14. Global Atezolizumab Sales Share by Manufacturer, 2017-2022
Table 15. Global Atezolizumab Price by Manufacturer (2017-2022) & (USD/Pcs)
Table 16. Global Atezolizumab Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Atezolizumab by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Atezolizumab as of 2021)
Table 18. Top Players of Atezolizumab in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Atezolizumab Product Type
Table 20. Date of International Manufacturers Enter into Atezolizumab Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Atezolizumab Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Atezolizumab Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Atezolizumab Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Atezolizumab Sales by Players, (K Pcs), 2020, 2021 & 2022
Table 26. United States Atezolizumab Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Atezolizumab Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Atezolizumab Sales in Volume by Region (2017-2022) & (K Pcs)
Table 29. Global Atezolizumab Sales in Volume Forecast by Region (2023-2028) & (K Pcs)
Table 30. Global Atezolizumab Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Atezolizumab Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Atezolizumab Sales in Volume by Country (2017-2028) & (K Pcs)
Table 33. North America Atezolizumab Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Atezolizumab Sales in Volume by Region (2017-2028) & (K Pcs)
Table 35. Asia Pacific Atezolizumab Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Atezolizumab Sales in Volume by Country (2017-2028) & (K Pcs)
Table 37. Europe Atezolizumab Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Atezolizumab Sales in Volume by Country (2017-2028) & (K Pcs)
Table 39. Latin Americaa Atezolizumab Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Atezolizumab Sales in Volume by Country (2017-2028) & (K Pcs)
Table 41. Middle East and Africa Atezolizumab Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Genentech (Roche) Corporation Information
Table 43. Genentech (Roche) Description and Business Overview
Table 44. Genentech (Roche) Atezolizumab Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 45. Genentech (Roche) Atezolizumab Product
Table 46. Genentech (Roche) Recent Development
Table 47. Key Raw Materials Lists
Table 48. Raw Materials Key Suppliers Lists
Table 49. Atezolizumab Customers List
Table 50. Atezolizumab Distributors List
Table 51. Research Programs/Design for This Report
Table 52. Key Data Information from Secondary Sources
Table 53. Key Data Information from Primary Sources
List of Figures
Figure 1. Atezolizumab Product Picture
Figure 2. Global Atezolizumab Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Atezolizumab Market Size 2017-2028 (US$ Million)
Figure 4. Global Atezolizumab Sales 2017-2028 (K Pcs)
Figure 5. United States Atezolizumab Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Atezolizumab Market Size 2017-2028 (US$ Million)
Figure 7. United States Atezolizumab Sales 2017-2028 (K Pcs)
Figure 8. United States Atezolizumab Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Atezolizumab Market Share in Global, in Volume (K Pcs) 2017-2028
Figure 10. Atezolizumab Report Years Considered
Figure 11. Product Picture of Use: Single Drug
Figure 12. Product Picture of Use: Chemotherapy Combination
Figure 13. Global Atezolizumab Market Share by Type in 2022 & 2028
Figure 14. Global Atezolizumab Sales in Value by Type (2017-2028) & (US$ Million)
Figure 15. Global Atezolizumab Sales Market Share in Value by Type (2017-2028)
Figure 16. Global Atezolizumab Sales by Type (2017-2028) & (K Pcs)
Figure 17. Global Atezolizumab Sales Market Share in Volume by Type (2017-2028)
Figure 18. Global Atezolizumab Price by Type (2017-2028) & (USD/Pcs)
Figure 19. United States Atezolizumab Market Share by Type in 2022 & 2028
Figure 20. United States Atezolizumab Sales in Value by Type (2017-2028) & (US$ Million)
Figure 21. United States Atezolizumab Sales Market Share in Value by Type (2017-2028)
Figure 22. United States Atezolizumab Sales by Type (2017-2028) & (K Pcs)
Figure 23. United States Atezolizumab Sales Market Share in Volume by Type (2017-2028)
Figure 24. United States Atezolizumab Price by Type (2017-2028) & (USD/Pcs)
Figure 25. Product Picture of Bladder Cancer
Figure 26. Product Picture of Lung Cancer
Figure 27. Product Picture of Advanced Triple-negative Breast Cancer
Figure 28. Product Picture of Head and Neck Cancer
Figure 29. Product Picture of Urothelial Carcinoma
Figure 30. Product Picture of Renal Cell Carcinoma
Figure 31. Product Picture of Hepatocellular Carcinoma (HCC)
Figure 32. Product Picture of Other
Figure 33. Global Atezolizumab Market Share by Application in 2022 & 2028
Figure 34. Global Atezolizumab Sales in Value by Application (2017-2028) & (US$ Million)
Figure 35. Global Atezolizumab Sales Market Share in Value by Application (2017-2028)
Figure 36. Global Atezolizumab Sales by Application (2017-2028) & (K Pcs)
Figure 37. Global Atezolizumab Sales Market Share in Volume by Application (2017-2028)
Figure 38. Global Atezolizumab Price by Application (2017-2028) & (USD/Pcs)
Figure 39. United States Atezolizumab Market Share by Application in 2022 & 2028
Figure 40. United States Atezolizumab Sales in Value by Application (2017-2028) & (US$ Million)
Figure 41. United States Atezolizumab Sales Market Share in Value by Application (2017-2028)
Figure 42. United States Atezolizumab Sales by Application (2017-2028) & (K Pcs)
Figure 43. United States Atezolizumab Sales Market Share in Volume by Application (2017-2028)
Figure 44. United States Atezolizumab Price by Application (2017-2028) & (USD/Pcs)
Figure 45. North America Atezolizumab Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 46. North America Atezolizumab Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 47. U.S. Atezolizumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 48. Canada Atezolizumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. Europe Atezolizumab Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 50. Europe Atezolizumab Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 51. Germany Atezolizumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 52. France Atezolizumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 53. U.K. Atezolizumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 54. Italy Atezolizumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. Russia Atezolizumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. Asia-Pacific Atezolizumab Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 57. Asia-Pacific Atezolizumab Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 58. China Atezolizumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Japan Atezolizumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. South Korea Atezolizumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. India Atezolizumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Australia Atezolizumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Taiwan Atezolizumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 64. Indonesia Atezolizumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 65. Thailand Atezolizumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 66. Malaysia Atezolizumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Philippines Atezolizumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Latin America Atezolizumab Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 69. Latin America Atezolizumab Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 70. Mexico Atezolizumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 71. Brazil Atezolizumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. Argentina Atezolizumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. Middle East & Africa Atezolizumab Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 74. Middle East & Africa Atezolizumab Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 75. Turkey Atezolizumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 76. Saudi Arabia Atezolizumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 77. U.A.E Atezolizumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 78. Atezolizumab Value Chain
Figure 79. Atezolizumab Production Process
Figure 80. Channels of Distribution
Figure 81. Distributors Profiles
Figure 82. Bottom-up and Top-down Approaches for This Report
Figure 83. Data Triangulation
Figure 84. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Genentech (Roche)